The new X5-1c transducer uses Philips' nSIGHT Plus is a proprietary imaging architecture that touches all aspects of image acquisition and processing, creating images with optimal resolution down to the pixel level, in contrast with conventional systems that form the image line by line.
December 10, 2021 – Philips Healthcare expanded its cardiac ultrasound portfolio with new imaging tools and features to increase diagnostic confidence and workflow efficiency. During its participation in the EuroEcho 2021 Virtual Congress, Dec. 9-11, Philips will showcase how its cardiac ultrasound solutions support cardiology patients and clinicians, from early detection, diagnosis and treatment, through ongoing assessment and long-term follow-up.
New Epiq and Affiniti Echocardiography Systems Integrate Informatics, Efficiency and Greater Diagnostic Confidence
Philips brings together the latest release of the Epiq CVx and Affiniti CVx ultrasound platforms, automated analysis, Collaboration Live remote diagnosis and Cardiovascular Workspace – IntelliSpace Cardiovascular – end-to-end workflow, for a fully integrated experience in echocardiography. Advanced technology is helping to foster first-time-right diagnosis and timely treatment.
Philips' nSIGHT Plus is a proprietary imaging architecture that touches all aspects of image acquisition and processing, creating images with optimal resolution down to the pixel level, in contrast with conventional systems that form the image line by line. In addition, the new Philips X5-1c transducer is designed to facilitate easier access to imaging windows between the ribs.
Clinician feedback showed that diagnostic confidence in 3D left ventricular function quantification was improved in 80% of patients undergoing transthoracic echo (TTE) exams using the X5-1c transducer. Philips said its artificial intelligence (AI)-enhanced Auto Measure application delivers fast and consistent measurements in half the time of manual methods. Using Auto Measure on Philips Epiq CVx and Affiniti CVx ultrasound systems can reduce the time for standard 2D echo measurements by 51%. Auto Measure AI and AutoStrain Left Atrium (LA) and Right Ventricle (RV) are now available across the Philips CVx portfolio.
“Imaging performance is the most important attribute to allow me to be confident in my diagnosis and treatment planning,” said Roberto Lang, M.D., director, noninvasive cardiac imaging laboratory, University of Chicago. During the European Society of Cardiology (ESC) virtual symposium, “Transthoracic echo like you’ve never seen before,” Lang explains how the new X5-1c echo transducer and AI-enhanced quantification are designed to improve clinical confidence in everyday patient care.
Enabling remote access and limiting risk of COVID-19 exposure, Philips echocardiography suite also includes Collaboration Live, an integrated tele-ultrasound solution providing remote access to clinical staff in real-time during exams.
“With echocardiography the first imaging modality utilized for a greater volume of patients,[1] clinicians are relying on ultrasound to provide care more than ever before,” said Jeff Cohen, general manager of ultrasound at Philips. “Cardiac imaging workflows need to be streamlined at every step to address the volume and complexity of cases. Philips echocardiography provides a connected ecosystem of integrated workflow solutions for cardiology. Combined with advanced diagnostic tools, our integrated solutions deliver clear insights on the patient’s condition quickly. These recent introductions also reinforce how our ultrasound capabilities bring strong clinical value to areas outside of echocardiography, including liver disease management, to help improve decision support and care at each step in the patient journey.”
See a couple of the new innovations for structural heart with the Epiq CVx in the VIDEO: New Echo Technology to Aid Structural Heart Interventions
For more information: www.philips.com.au/healthcare/resources/landing/echocardiography
Find more echocardiography content
Reference:
July 25, 2024 
